INDGNIndegene Limited
Convert to ideaHealthcare · Healthcare Services
The verdict combines business quality, price and timing. Sign in free to see it.
Sign in freeDown 0.3 this quarter.
Momentum from moving averages, Supertrend and RSI.
3 forensic issues found. Sign in to see which.
Valuation Metrics
Q2 FY2027Intrinsic value, Graham number and DCF against today's price
3 found · risk elevated
Quality, growth, balance sheet and earnings quality behind the score
ⓘ Based on fundamental & forensic analysis. Always verify against official filings and consult a financial advisor.
Financial Metrics
Comparing Q2 FY2027 vs Q2 FY2026
| Quarter | Revenue | Net Profit | OPM | NPM | EPS | Int. Cover |
|---|---|---|---|---|---|---|
| Q2 FY2027 | ₹1122 Cr | ₹112 Cr | 12.41% | 10.01% | ₹4.67 | 22.4x |
| Q1 FY2027 | ₹1063 Cr | ₹116 Cr | 12.24% | 10.93% | ₹4.84 | 24.9x |
| Q4 FY2026 | ₹1003 Cr | ₹80 Cr | 12.14% | 7.94% | ₹3.32 | 15.6x |
| Q3 FY2026 | ₹942 Cr | ₹103 Cr | 12.73% | 10.92% | ₹4.29 | 30.3x |
| Q2 FY2026 | ₹804 Cr | ₹102 Cr | 14.57% | 12.70% | ₹4.26 | 36.0x |
| Q1 FY2026 | ₹761 Cr | ₹116 Cr | 17.57% | 15.30% | ₹4.86 | 42.1x |
Momentum score, 1-year chart, moving averages, support and resistance.
Turnaround stage, and how each measure moved over 3 years against the company's own range.
Order wins, capex, pledges, rating actions and every material filing.
Management guidance, Q&A highlights and whether they delivered what they said.
The earnings call read across investor dimensions.
Promoter, FII and mutual fund holding, and what changed this quarter.
Similar-size peers in Healthcare Services
Compare with peers →Indegene Limited operates as a digital-first life sciences commercialization company in India, the United States, Europe, and internationally. It operates through three segments: Enterprise Medical Solutions, Enterprise Commercial Solutions, Omnichannel Activation & Others. The company develops biotech and medical device for biopharmaceutical, emerging biotech, and medical device companies. It also offers enterprise commercial, medical, and clinical solutions; and omnichannel activation solutions. In addition, the company operates NEXT technology platforms. Further, it provides analytics, technology, commercial, medical, regulatory, and safety services to life science and healthcare organizations. Indegene Limited was incorporated in 1998 and is based in Bengaluru, India.
Note: This comprehensive analysis combines technical data, fundamental data, and investment thesis. Always do your own research and consider your personal risk tolerance before investing.